Infinity Pharmaceuticals, Inc.
TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS

Last updated:

Abstract:

Provided herein are methods, kits, and pharmaceutical compositions that include a P13 kinase inhibitor for treating cancers or hematologic disorders.

Status:
Application
Type:

Utility

Filling date:

14 Apr 2020

Issue date:

4 Mar 2021